ETHA Statement on Lessons learned from COVID-19: the need for better thrombosis management
ETHA contributes to the EU Non-Communicable Diseases Initiative
Statement from the International Society on Thrombosis and Haemostasis on Reports Indicating Blood Clots Associated with the AstraZeneca Vaccine
European Thrombosis and Haemostasis Alliance Welcomes European Medicines Agency Decision on COVID-19 Vaccination and Blood Clots
Saving and Improving Lives by Addressing Cancer-Associated Thrombosis
European Thrombosis and Haemostasis Alliance Elects Prof. Ingrid Pabinger-Fasching as Chair
Watch the Recorded Webinar on the Role of Public Affairs
Joint Statement on Cancer-Associated Thrombosis with the European Cancer Patient Coalition
ETHA Recognises World Thrombosis Day on 13 October
Consensus Statement: A Systematic Approach for Managing Venous Thromboembolism in Patients with COVID-19
Europe’s Beating Cancer Plan – Consultation Responses Submitted
ETHA Signs a Joint Statement on Cancer Comorbidities
ETHA Statement for Universal Health Coverage Day on 12 December
Cancer-Associated Thrombosis Roundtable Brings Together MEPs and Stakeholders
Proud to Partner: World Thrombosis Day on 13 October
Invitation: Cancer-Associated Thrombosis Roundtable Discussion at the EU | 16 October
ETHA Members Attend the 69th Session of the WHO Regional Committee for Europe
ETHA Celebrates World Patient Safety Day on 17 September
Giving the Thrombosis and Hemostasis Community a Voice to Drive Prioritisation
European Commission Relevant Calls for Proposals
ETHA: How Partnerships Can Increase Impact
ETHA Holds Inaugural Event at the European Parliament with Host MEP Aldo Patriciello
ETHA Issues Consensus Statement
European Thrombosis and Haemostasis Alliance Launches
World Thrombosis Day Impact Report Now Available
New Paper On Low Global Public Awareness of Atrial Fibrillation & Link To Stroke